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pressed the view that totally eliminating
the use of animals in testing appears
unlikely for the foreseeable future. Stokes
explained that despite some limitations of
current animal models used for testing,
they remain useful and necessary for the
protection of human health. "The degree
of relevance of information [to humans]
depends on the specific animal model
used, our understanding ofthe model, and
toxicity endpoint studied," he pointed out.
Balls, however, believes that animal testing
can be entirely replaced in the future.
"When I'm optimistic, I think it can be
done in 25 years. When I feel pessimistic, I
think in terms of50 years."
Although a specific deadline for replac-
ing animal models was not an outcome of
the meeting, George Lucier, director ofthe
Environmental Toxicology Program at the
NIEHS, believes the meeting was a signifi-
cant step in the right direction for several
reasons. "This meeting produced a signifi-
cant broadening ofthe definition of alter-
native models to include such things as
mechanistic data and mathematical mod-
els," he said. "And most importandy, all of
the stakeholders bought into the ideas put
forth for improving, especially streamlin-





The Great Lakes are on the
mend, according to recent
reports on the overall health of
the world's largest body of fresh
water. Yet persistent toxic com-
pounds continue to be dumped into the
lakes, and PCBs, DDT, and other chemi-
cals can stil be detected in lake sediments
and fish, causing potential health problems
for people who eat the fish. New health
studies indicate that pollution ofthe Great
Lakes could be contributing to subtle
health concerns in the region induding a
reduction in human sperm counts, higher
rates of breast cancer, low birth-weight
babies, andlearning disabilities in children.
The U.S. EPA and Environment
Canada concluded that water quality and
human health are improving in the Great
Lakes region, but the results are mixed.
The agencies presented these findings in
the State ofthe GreatLakes 1995, a bienni-
al report released inSeptember.
"I think it's safe to say this: there's no
doubt that contaminants are declining,"
says Harold Humphrey, veteran research
scientist for the Michigan Department of
Public Health. "Things are a bit berter. But
the question remains, what is going to hap-
pen with all of these subde health effects?
No one can answer that question yet."
The Great Lakes have been a receptacle
for awide variety ofpollutants for decades,
induding DDT, PCBs, pesticides, dioxin,
and more. It is a heavily industrialized
region: about one-fifth ofAmerican indus-
try and one-half of Canadian industry are
located along the Great Lakes or tributary
streams. Forty-two shoreline areas in the
Great Lakes, such as Indiana Harbor,
Milwaukee Harbor, and Green Bay
Harbor, have been designated as "areas of
concern"-the most degraded sites in the
basin-by the EPA and Environment
Canada. Thirty-five ofthe areas ofconcern
have public advisories against fish con-
sumption.
In view of the number of people con-
suming fish and the potential human
health impacts, the International Joint
Commission (IJC) Great Lakes Water
Quality Board called for a zero discharge of
persistent toxicants into the Great Lakes in
its seventh biennial report titled 1993-
-1995 Priorities and Progress Under the
Great Lakes Water Quality Agreement.
"Society must adopt a clear.and compre-
hensive action plan to vir-
tually eliminate persistent
toxic substances that are
threatening human health
and the future ofthe Great
Lakes ecosystem," the
report said. That goal has
yet to be achieved.
On the bright side, re-
_IW search detailed in the Siate ofthe
Great Lakes 1995 shows that levels of
DDT in women's breast milk (from
women living in a number of Canadian
cities in the Great Lakes area) have dedined
87% from more than 150 parts per million
in 1967 to 20 ppm in 1986. The levels of
PCBs in women's breast milk also has
declined. Results ofa Lake Michigan study
conducted by the Wisconsin Department
of Natural Resources show the amount of
PCBs in lake trout and salmon has
decreased by 80%.
In its report, the IJC advocates pollu-
tion prevention as an immediate step that
industry can take to help reduce persistent
toxicants in the Great Lakes. The water
quality board recommended that bina-
tional initiatives be adopted to build on
those gains, including new benchmarks,
management guidelines, and increased
monitoring.
John Westendorf, manager of water
quality and corporate environmental affairs
for Occidental Chemical Corporation in
Niagara Falls, New York, said his compa-
ny's Niagara Falls plant has reduced its air,
water, and hazardous waste discharges by
73% in the past five years.
"Industry is committed to doing a bet-
terjob as long as we're given some flexibili-
ty," Westendorfsays.
But Occidental opposes a zero-dis-
charge standard, Westendorfsays. At mini-
mum, chemicals are needed to control exot-
ic species such as the sea lamprey and zebra
mussel, he says. Sea lampreys prey on lake
trout and other game fish, and zebra mus-
sels clog water-intake pipes for utilities and
industries. Both exotic species have prolifer-
ated in the Great Lakes bythe millions.
Burkhard Mausberg, executive director
of Great Lakes United in Buffalo, New
York, says his organization supports zero
discharge and ecosystem management to
improve the Great Lakes. But he sees few
advances toward those goals in the politi-
callycharged policy arena.
Mausberg notes that the U.S. Congress
has pondered deep cuts in renewing the
Clean Water Act and EPA enforcement.
"What we're finding is the environmental
programs that are most progressive are
being cut. We don't need that right now,"
he says.
The Great Lakes Initiative, launched
by former President Bush and carried on
by President Clinton, envisions uniform
pollution-discharge standards for all the
Great Lakes states. It has been opposed by
most states thus far for economic reasons,
officials say.
While politics muddies the waters for
now, the IJC's Great Lakes Science
Advisory Board has called for more
research into the impacts of chemicals on
the reproductive, developmental, and
immune systems in animals and humans.
New research indicates that the discharge
of PCBs, pesticide residues, and dioxin
into the Great Lakes could be causing hor-
monal changes in some fish, birds, and
mammals.
The research is preliminary, according
to Theo Colborn of the World Wildlife
Fund, who is authoring a book on envi-
ronmental estrogens. But the effects on fish
could also materialize in humans, she says.
According to Humphrey, it's too early to
tell how substantial the risk is for humans.
"The concern among public health profes-
sionals is that we don't cry wolftoo much
so people believe us when the real wolf
comes along," he says.
East Meets Westfor Improved
Antimalarials
Malaria is one ofthe world's greatest pub-
lic health problems, striking 200-300 mi-
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lion people yearly, and killing at least a
million. The intracellular protozoan para-
sites that cause the disease are endemic in
tropical areas and are spread by mosqui-
toes. In many areas, especially southeast
Asia, the parasite has become resistant to
existing antimalarials such as chloroquine.
Now with some help from western sci-
ence, an ancient Chinese herbal remedy
mayserve as the prototype for anewfamily
ofantimalarial drugs. At least three million
malaria patients have been treated with the
folk medicine, but it is far from a perfect
remedy. Western scientists hope to
improve the drug by changing its chemical
makeup. In 1972, Chinese scientists redis-
covered qinghaosu. This plant extract is
derived from the leaves ofArtemisia annua
a prolific shrub related to wormwood, and
has been used against fever for 2000 years.
The western name for the active compo-
nent is artemisinin. When the Chinese
found that it fought malaria, they put it
into clinical use. So far, the malaria para-
sites have shown no resistance to the sub-
stance, nor is artemisinin toxic at dinical
doses. And itworks quickly.
"It's very good for treating severe, life-
threatening malaria," says Steven R.
Meshnick, a parasitologist, biochemist, and
associate professor ofepidemiology at the
University ofMichigan School of Public
Health. Artemisinin revives comatose
patients much faster than quinine. But it's
not a cure. It's less useful in milder cases
and thedisas frequentlyreturns. Thedrug
is also poorly water soluble and difficult to
administer orally. And the body eiminates
itquickly, so itmustbetakenfrequently.
However, "Once you know exactly
where the drug works, and how, you can
then design it to work better," says
Meshnick. The essential part of the
artemisinin molecule is a peroxide bridge, a
chemical structure that's unusual and often
unstable. The molecule's selective toxicity is
due to the malaria parasite's diet ofhemo-
globin. The parasite digests the globin por-
tion but can't metabolize the iron-contain-
ing heme structure, which it stores in
hemozoin granules. The peroxide bridge
interactswith the iron andhemeexposed in
these granules to produce short-lived, high-
ly reactive free radicals. These free radicals
or related reactive intermediates damage
critical proteins in the parasite, killing it.
Thoughheme exists throughout thehuman
body, it's tucked inside proteins and thus
protectedfrom this reaction.
Artemisinin is a complex, multiringed
molecule, but all the rings aren't necessary
for the antimalarial effect. "We've tried to
simplifr the structure and arrive at com-
pounds that are equally potent and yet are
much easier to prepare in. the lab," says
Gary Posner, a medical chemist at Johns
Hopkins University. Posnerandothers have
used this mechanism-based design strategy
to synthesize hundreds of artemisinin
analogs, some ofwhich are as effectiVe as
artemisinin inanimalstudies.
Michael Bentley, chairperson of the
Department of Chemistry at the
University ofMaine, has employed a dif-
ferent tactic. Bendey attached artemisinin
to polymers ofpolyethylene glycol, a non-
toxic, nonallergenic compound used in
foods and drugs. Resulting compounds
tend to be soluble both in water and in
nonpolar solvents. Such structural modifi-
cations may lengthen artemisinin's stay in
the body. Plus, each polymer carries two
peroxide bridges. In studies with mice,
some of Bentley's compounds show
NrsIreumedy. Workers atthe I rnst of Malaria, Parasitology, and Entofmology in Hanoi, Vietnam,
gatherleavesofArtmisia annus,which contain a potential malaria treatmentdrug.
improved activity over artemisinin alone,
orchloroquine alone.
Artemisinin-based drugs are promising,
experts agree, but the coevolutionary arms
race with the malaria parasite will contin-
ue. Given the opportunity, the parasitewill
develop resistance. "Nothing is a cure-all,
magic bullet for all time," says Bentley.
Meshnick concurs, but notes that although
penicillin wasn't perfect either, it served as
a prototype for a whole new family of
antibiotics. "I really think the same thing
can happen forartemisinin," he says.
What's Causing Parkinson's?
The cause of Parkinson's disease has baf-
fled doctors ever since this chronic neuro-
logical syndrome was first described by
James Parkinson in 1817. Now scientists
may finally be closing in on the culprits.
The disease is likely to be caused by "some
admixture ofgenetic predisposition, aging,
and exposure to environmental toxicants,"
says Doyle Graham, chair ofthe pathology
department atVanderbilt UniversityMedi-
cal Center in Nashville.
Sorting out multiple potential causal
agents and the interactions among them
will never be easy. However, thanks to
increasingly sophisticated research tech-
niques, it may now be possible. A prime
example of the kind of meticulously
designed research needed for this purpose
is a case-control study currently being
completed at Henry Ford Health System
in Detroit. "This is one ofonly two popu-
lation-based studies to date in Parkinson's
epidemiology, and it's the only one of
which I'm aware in which an industrial
hygienist's assessment of exposures, based
ondetailed occupational histories, has been
used," saysJay M. Gorell, lead investigator
and director of the hospital's Parkinson's
disease center.
The study, now in the final data analy-
sis stage, induded 144 Parkinson's patients
and 469 control subjects who were
matched for age, race, and sex. Preliminary
analyses, based on all but 10 ofthe patients
and all but six of the controls, suggest an
increased risk ofParkinson's disease associ-
ated with exposure to manganese, copper,
and lead, as well as exposure to herbicides
and insecticides used at work. However, it
may take some combination of factors to
*produce Parkinson's disease. "It's possible
that an agent might act in a cumulative
wayovertime to partially disable acell, but
it might take several agents together to
cause the cell either to fail to finction or to
dieprematurely," says Gorell.
While some researchers are devoting
their energies to determining which envi-
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